Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN) Fair Value & Analysis
Utilities · TR · Market cap 8.8B TRY
Fair value as of: Aug 5, 2026
From 9 valuation models · updated today
Share price −4.6% over the past month.
Below-average quality, and screening another 89% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (3.25 TRY). The favourable scenario is already priced in.
- Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 5, 2026.
How to read this chart
60‑month range 4.74 TRY – 27.12 TRY · fair‑value band 1.96 TRY – 3.25 TRY · the 17.90 TRY price screens above the 1.96 TRY fair value. Dashed = 300-day average. As of Aug 5, 2026.
Analysis
Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN) currently trades at 17.90 TRY, while our model-based Fair Value estimate is 1.96 TRY, implying the stock looks roughly 89.1% overvalued today. We read business quality at 27/100 (below-average quality), in the Utilities sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Biotrend Cevre ve Enerji Yatirimlari A.S. generated revenue of 2.8B TRY at a net margin of -30.4%. Revenue declined 13.7% year over year. It earns a return on equity of -23.3%. Net debt stands at 4.9B TRY. Fundamentals as of Aug 5, 2026
Our scenario range runs from 1.96 TRY (bear case) to 3.25 TRY (bull case); at 17.90 TRY, the current price sits above that range. The share trades about 36% below its 52-week high and 22% above its 52-week low, currently below its 200-day average. For context, the median of 10 Utilities peers we cover trades at -30% fair-value upside, at -89%, BIOEN screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Asset-Based (3.74 TRY) versus Growth DCF (0.3100 TRY). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 5, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 29 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Biotrend Cevre ve Enerji Yatirimlari A.S. engages in integrated waste management-oriented renewable energy, circular raw materials, and fuel production activities in Turkey.
Full company description
Biotrend Cevre ve Enerji Yatirimlari A.S. engages in integrated waste management-oriented renewable energy, circular raw materials, and fuel production activities in Turkey. It is involved in the waste disposal; mechanical sorting; recycled products; refuse-derived fuel; generation of electricity and heat from biogas, landfill gas, and biomass; carbon trading; composting; sanitary landfills; and greenhouse farming. The company also engages in production of energy using fermentation, , incineration technologies; operation of solid waste storage areas, mechanical separation plant, waste derived fuel preparation plant, leachate treatment plant, biological treatment plant, and landfill gas; and installation and operation of power generation plants, as well as provision of engineering, contracting, and consulting services. The company was founded in 2017 and is headquartered in Istanbul, Turkey. Biotrend Cevre ve Enerji Yatirimlari A.S. operates as a subsidiary of Doganlar Investment Holding A.S.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Biotrend Cevre ve Enerji Yatirimlari A.S. reported revenue of 2.9B TRY in FY2025 versus 428M TRY in FY2021, a compound +62.0%/yr. Reported net income was −1.4B TRY in FY2025.
BIOEN screens 89% overvalued. Compare with China Yangtze Power Co →
Peer Group
Utilities - Renewable · 220 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Utilities - Renewable median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Utilities - Renewable stocks, each showing price versus our Fair Value estimate (as of Aug 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| China Yangtze Power Co 600900 | ¥27.99 | ¥25.13 | -10% |
| Ørsted A/S ORSTED | kr 149.70 | kr 31.40 | -79% |
| Huaneng Lancang River Hydropower Inc 600025 | ¥9.81 | ¥5.57 | -43% |
| Adani Green Energy Limited ADANIGREEN | ₹1,537 | ₹170.50 | -89% |
| AXIA Energia SA AXIAP | $10.74 | $9.65 | -10% |
| VERBUND AG OEWA | €58.65 | €66.19 | +13% |
| BEP BEP | $32.33 | $73.35 | +127% |
| BEPUN BEPUN | C$44.56 | C$10.15 | -77% |
| Fortum Oyj FORTUM | €19.89 | €13.90 | -30% |
| China Longyuan Power Group 001289 | ¥16.21 | ¥8.23 | -49% |
Compare Biotrend Cevre ve Enerji Yatirimlari A.S. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Utilities stocks →
Frequently asked questions
Is Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN) overvalued or undervalued?
What is the fair value of BIOEN?
What is the quality score of BIOEN?
What is the revenue of Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN)?
What is the net profit margin of BIOEN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Biotrend Cevre ve Enerji Yatirimlari A.S. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.